Combined scleral buckle and BGI is effective

Article

Combined scleral buckle and Baerveldt glaucoma implantation (BGI) is effective for managing coexisting glaucoma and retinal detachment.

Combined scleral buckle and Baerveldt glaucoma implantation (BGI) is effective for managing coexisting glaucoma and retinal detachment, while minimizing surgical risk, states a journal paper.

Professor V.C. Lima et al., Department of Ophthalmology and Einhorn Clinical Research Center, The New York Eye and Ear Infirmary, New York, USA, included 30 eyes of 30 patients in a retrospective, consecutive, noncomparative, interventional case series.

All patients underwent simultaneous scleral and BGI surgery and were separated into a staged BGI group of 21 patients and a non-staged BGI group consisting of 9 patients. Successful IOP control was identified as 6 mmHg ≤ IOP ≤ 18 mmHg.

Mean best-corrected visual acuity improved from 2.0 preoperatively to 1.7 postoperatively. In the staged group 62% required second-stage tube insertion postoperatively. Mean IOP was reduced from 31.1±10.8 to 12.7±6.0 mmHg, mean number of glaucoma medications was lowered from 2.9±1.4 to 1.2±1.3.

Combined scleral buckle and BGI is a successful management technique for coexisting glaucoma and retinal detachment and greatly reduces surgical risk.

Please visit the Journal of Glaucoma for more information.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.